Merck and the pharmaceutical industry are headline news today.
Controversies over public safety, prices, and the ability of the
industry to develop the new drugs and vaccines that society needs
have been covered worldwide. Roy Vagelos, who was head of research
and then CEO at Merck from the mid-1970s through the early 1990s,
addresses these issues here. Success with targeted research started
Merck on a path that would lead to a series of block-buster
therapies that carried the firm to the top of the global industry
in the 1990s and Vagelos into the top position at the company.
Trained as a physician and scientist, he had to learn how to run a
successful business while holding to the highest principles of
ethical behavior. He was not always successful. He and his
co-author explain where and why he failed to achieve his goals and
carefully analyze where he succeeded.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!